[Management of biliary tract carcinomas]
- PMID: 19462864
[Management of biliary tract carcinomas]
Abstract
Biliary tract carcinomas are rare tumours, counting for less than 5% of cancer. Biliary tract carcinomas comprise gallbladder carcinoma and cholangiocarcinoma, which arise from the intrahepatic or extrahepatic bile ducts. These tumours have a poor prognosis, with a median survival of 6 months for advanced disease. Surgical resection is the only potentially curative therapy. Adjuvant treatement by chemotherapy, radiotherapy or radio-chemotherapy might be an option after surgery, however no standard therapy is define. For advanced disease, despite progress of palliative chemotherapy, there is no standard therapy.
Similar articles
-
Treatment of patients with unresectable advanced carcinoma of biliary tract - chemotherapy and surgical resection.Anticancer Res. 2009 May;29(5):1783-6. Anticancer Res. 2009. PMID: 19443404
-
[Diagnostics and treatment of cholangiocarcinoma].Ned Tijdschr Geneeskd. 2008 May 3;152(18):1037-41. Ned Tijdschr Geneeskd. 2008. PMID: 18547024 Review. Dutch.
-
Therapeutic approach to the malignant tumors of the biliary tract.Rom J Intern Med. 2010;48(2):131-40. Rom J Intern Med. 2010. PMID: 21428177 Review.
-
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.Oncology (Williston Park). 2004 Jul;18(8):1049-59; discussion 1060, 1065-6, 1068. Oncology (Williston Park). 2004. PMID: 15328897 Review.
-
Status of surgical treatment of biliary tract cancer.Dig Surg. 2007;24(2):131-6. doi: 10.1159/000101901. Epub 2007 Apr 19. Dig Surg. 2007. PMID: 17446708 Review.
Cited by
-
RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.Int J Mol Sci. 2011 Jan 14;12(1):385-400. doi: 10.3390/ijms12010385. Int J Mol Sci. 2011. Retraction in: Int J Mol Sci. 2017 Jul 10;18(7):E1483. doi: 10.3390/ijms18071483. PMID: 21339993 Free PMC article. Retracted.